Literature DB >> 31552770

The impact of smoking on the effectiveness of immune checkpoint inhibitors - a systematic review and meta-analysis.

Kirsty Wai Chung Lee1, Sarah J Lord2,3, Lawrence Kasherman1, Ian Marschner2,4, Martin Stockler2, Richard Gralla5, James Chih-Hsin Yang6,7, Tony Mok8, Chee Khoon Lee1,2.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31552770     DOI： 10.1080/0284186X.2019.1670354

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  7 in total

1.  Smoking history and the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Da-Li Chen; Qing-Yuan Li; Qun-You Tan
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

2.  The effect of smoking status on efficacy of immune checkpoint inhibitors in metastatic non-small cell lung cancer: A systematic review and meta-analysis.

Authors:  Linzheng Dai; Bo Jin; Tingting Liu; Jun Chen; Guang Li; Jun Dang
Journal:  EClinicalMedicine       Date:  2021-06-26

3.  Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Wenhua Zhao; Wei Jiang; Huilin Wang; Jianbo He; Cuiyun Su; Qitao Yu
Journal:  Front Oncol       Date:  2021-08-23       Impact factor: 6.244

4.  Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations.

Authors:  Alessio Cortellini; Biagio Ricciuti; Victor R Vaz; Davide Soldato; Joao V Alessi; Filippo G Dall'Olio; Giuseppe L Banna; Sethupathi Muthuramalingam; Samuel Chan; Margarita Majem; Aida Piedra; Giuseppe Lamberti; Elisa Andrini; Alfredo Addeo; Alex Friedlaender; Francesco Facchinetti; Teresa Gorría; Laura Mezquita; Delphine Hoton; Lacroix Valerie; Frank Aboubakar Nana; James Artingstall; Charles Comins; Massimo Di Maio; Andrea Caglio; Judith Cave; Hayley McKenzie; Thomas Newsom-Davis; Joanne S Evans; Marcello Tiseo; Antonio D'Alessio; Claudia A M Fulgenzi; Benjamin Besse; Mark M Awad; David J Pinato
Journal:  J Immunother Cancer       Date:  2022-02       Impact factor: 13.751

5.  Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis.

Authors:  Qian Qin; Tomi Jun; Bo Wang; Vaibhav G Patel; George Mellgard; Xiaobo Zhong; Mahalya Gogerly-Moragoda; Anish B Parikh; Amanda Leiter; Emily J Gallagher; Parissa Alerasool; Philip Garcia; Himanshu Joshi; Matthew Galsky; William K Oh; Che-Kai Tsao
Journal:  Discov Oncol       Date:  2022-08-12

Review 6.  Effect of Smoking on Treatment Efficacy and Toxicity in Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  Marie Bergman; Georgios Fountoukidis; Daniel Smith; Johan Ahlgren; Mats Lambe; Antonios Valachis
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

Review 7.  Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.

Authors:  Lucy K Corke; Janice J N Li; Natasha B Leighl; Lawson Eng
Journal:  Curr Oncol       Date:  2022-08-30       Impact factor: 3.109
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.